GRI Bio (GRI) Property, Plant & Equipment (Net) Growth (1y) (2023 - 2026)

GRI Bio (GRI) Property, Plant & Equipment (Net) Growth (1y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	PP&E (Net) Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	24.71%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	12.77%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-99.85%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-5.07%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	1.70%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	10.87%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	70.79%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	19.14%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	GRI Bio	3.01 Mn	3.01 Mn	-	-

Download Data